SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target
Year: 2025
Type: article
Abstract: Metastatic uveal melanomas are highly resistant to all existing treatments. To identify actionable vulnerabilities, we conducted a CRISPR-Cas9 knockout screen using a library composed of chromatin regulators. We revealed that the lysine methyltransferase, SETDB1, plays a critical role in metastatic uveal melanoma cell proliferation and survival. Functionally, SETDB1 deficiency induces a DNA damage response, senescence-like state and growth arrest. Knockdown of SETDB1 is associated with a decreased expression of genes related to replication and cell cycle. Moreover, deficiency in CDC6, an essential regulator of DNA replication, phenocopies SETDB1 inhibition. Using a pre-clinical model, we further demonstrated that anti-SETDB1 therapy impairs tumor growth in vivo. Therefore, we not only provide evidence that SETDB1 plays a critical role in metastatic uveal melanoma cell growth, but we also identify SETDB1 as a novel relevant therapeutic target for the treatment of metastatic uveal melanoma.
Source: Cell Death and Disease
Authors: Imène Krossa, Céline Pisibon, Yann Cheli, Karine Bille, Mélanie Dalmasso, Sabah Hamadat, Chrystel Husser, Marie Irondelle(Methodology, Software), Julien Cherfils-Vicini, Frédéric Soysouvanh, Sacha Nahon-Esteve, Arnaud Martel, Sandra Lassalle, Jean-Pierre Caujolle, Célia Maschi, Stéphanie Baillif, Dan Hasson(Methodology, Software), Saul Carcamo(Methodology, Software), Andrew E. Aplin, Irwin Davidson, Emily Bernstein, Valeria Naim, Robert Ballotti(Conceptualization, Data curation, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing), Corine Bertolotto(Conceptualization, Data curation, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing), Thomas Strub(Conceptualization, Data curation, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Inserm, Université Côte d'Azur, Hôpital l'Archet, Centre Méditerranéen de Médecine Moléculaire, Centre National de la Recherche Scientifique, Université Paris-Saclay, Institut Gustave Roussy, Intégrité du génome et cancers, Inovarion (France), Institut de Recherche sur le Cancer et le Vieillissement de Nice, Centre Hospitalier Universitaire de Nice, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia University, Institut de génétique et de biologie moléculaire et cellulaire, Université de Strasbourg
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,990
OpenAlex ID: W4415522277
